Image Contrast, Image Pre-Processing, and T(1) Mapping Affect MRI Radiomic Feature Repeatability in Patients with Colorectal Cancer Liver Metastases

Por McHugh, Damien J., Porta, Nuria, Little, Ross A., Cheung, Susan, Watson, Yvonne, Parker, Geoff J. M., Jayson, Gordon C., O’Connor, James P. B.
Publicado no Cancers (Basel) (2021)

Data‐driven mapping of hypoxia‐related tumor heterogeneity using DCE‐MRI and OE‐MRI

Por Featherstone, Adam K., O'Connor, James P.B., Little, Ross A., Watson, Yvonne, Cheung, Sue, Babur, Muhammad, Williams, Kaye J., Matthews, Julian C., Parker, Geoff J.M.
Publicado no Magn Reson Med (2017)

Diffusion model comparison identifies distinct tumor sub‐regions and tracks treatment response

Por McHugh, Damien J., Lipowska‐Bhalla, Grazyna, Babur, Muhammad, Watson, Yvonne, Peset, Isabel, Mistry, Hitesh B., Hubbard Cristinacce, Penny L., Naish, Josephine H., Honeychurch, Jamie, Williams, Kaye J., O'Connor, James P. B., Parker, Geoffrey J. M.
Publicado no Magn Reson Med (2020)

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study

Por Mahmood, Reem D., Shaw, Danielle, Descamps, Tine, Zhou, Cong, Morgan, Robert D., Mullamitha, Saifee, Saunders, Mark, Mescallado, Nerissa, Backen, Alison, Morris, Karen, Little, Ross A., Cheung, Susan, Watson, Yvonne, O’Connor, James P. B., Jackson, Alan, Parker, Geoff J. M., Dive, Caroline, Jayson, Gordon C.
Publicado no BMC Cancer (2021)

Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology

Por Little, Ross A., Jamin, Yann, Boult, Jessica K. R., Naish, Josephine H., Watson, Yvonne, Cheung, Susan, Holliday, Katherine F., Lu, Huiqi, McHugh, Damien J., Irlam, Joely, West, Catharine M. L., Betts, Guy N., Ashton, Garry, Reynolds, Andrew R., Maddineni, Satish, Clarke, Noel W., Parker, Geoff J. M., Waterton, John C., Robinson, Simon P., O’Connor, James P. B.
Publicado no Radiology (2018)

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

Por Jayson, Gordon C., Zhou, Cong, Backen, Alison, Horsley, Laura, Marti-Marti, Kalena, Shaw, Danielle, Mescallado, Nerissa, Clamp, Andrew, Saunders, Mark P., Valle, Juan W., Mullamitha, Saifee, Braun, Mike, Hasan, Jurjees, McEntee, Delyth, Simpson, Kathryn, Little, Ross A., Watson, Yvonne, Cheung, Susan, Roberts, Caleb, Ashcroft, Linda, Manoharan, Prakash, Scherer, Stefan J., del Puerto, Olivia, Jackson, Alan, O’Connor, James P. B., Parker, Geoff J. M., Dive, Caroline
Publicado no Nat Commun (2018)

Quantifying anti-vascular effects of monoclonal antibodies to VEGF: insights from multi-modality cross species imaging in colorectal cancer

Por O’Connor, James P B, Carano, Richard A D, Clamp, Andrew R, Ross, Jed, Ho, Calvin C K, Jackson, Alan, Parker, Geoff J M, Rose, Chris J, Peale, Franklin V, Friesenhahn, Michel, Mitchell, Claire L, Watson, Yvonne, Roberts, Caleb, Hope, Lynn, Cheung, Sue, Reslan, Hani Bou, Go, Mary Ann T, Pacheco, Glenn J, Wu, Xiumin, Cao, Tim C, Ross, Sarajane, Buonaccorsi, Giovanni A, Davies, Karen, Hasan, Jurjees, Thornton, Paula, del Puerto, Olivia, Ferrara, Napoleone, van Bruggen, Nicholas, Jayson, Gordon C
Publicado no Clin Cancer Res (2009)